NPI | Name | Type | Address |
---|---|---|---|
DR. PHARM.D. Stephen Lirette |
Individual |
2000 6th Ave S Birmingham, AL |
|
Cancer Partners Of Nebraska Pc |
Organization |
201 S 68th Street Pl Ste 200 Lincoln, NE |
|
RPH Donita Harris |
Individual |
8901 Carti Way Little Rock, AR |
|
PHARMD Nicholas Jacob Coulter |
Individual |
224 W Exchange St Ste 180 Akron, OH |
|
PHARMD, BCPS Niree Kalfayan |
Individual |
9090 Wilshire Blvd Ste 250 Beverly Hills, CA |
|
Morgan Elizabeth Cantley |
Individual |
800 Rose St Rm H110 Lexington, KY |
|
PHARMD Maegan S Rose |
Individual |
1545 Airport Blvd Pensacola, FL |
|
David Rozolsky |
Individual |
1 Medical Center Dr Lebanon, NH |
|
PHARMD Lindsey Lu |
Individual |
3801 Miranda Ave Palo Alto, CA |
|
Stephanie Alexandra Monaco |
Individual |
1275 York Ave New York, NY |
|
DR. Amber D. Baker |
Individual |
251 Park Dr Downingtown, PA |
|
Pattianne Lozano |
Individual |
667 Eastland Ave Se Warren, OH |
|
DR. BS, MBA, PHARMD Jimmy Lee |
Individual |
3551 Roger Brooke Dr Fort Sam Houston, TX |
|
DR. PHARM.D Lisa Marie Grate |
Individual |
234 Goodman St Cincinnati, OH |
|
DR. PHARMD Brooke Ashley Peters |
Individual |
234 Goodman St Cincinnati, OH |
|
Stephanie Johnson |
Individual |
1090 Nebraska Medicine Omaha, NE |
|
RPH Puja Patel |
Individual |
9090 Wilshire Blvd Ste 200 Beverly Hills, CA |
|
Frances Shuk Kwan Fu |
Individual |
9500 Euclid Ave Cleveland, OH |
|
PHARMD Ligi Mathews |
Individual |
3991 Powell Rd Chester Springs, PA |
|
PHARMD Anli Mccoy |
Individual |
2139 Auburn Ave Cincinnati, OH |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |